Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction: The TIME Randomized Trial

Traverse, J.; Henry, T.; Pepine, C.; Willerson, J.; X M Zhao, David; Ellis, S.; Forder, J.; Anderson, R.; Hatzopoulos, A.; Penn, M.; Perin, E.; Chambers, J.; Baran, K.; Raveendran, Ganesh; Lambert, C.; Lerman, A.; Simon, D.; Vaughan, D.; Lai, D.; Gee, A.; A Taylor, Doris; Cogle, C.; D. Thomas, James; E. Olson, Rachel; Bowman, Sherry; Francescon, Judy; Geither, Carrie; Handberg, E.; Kappenman, Casey; Westbrook, Lynette; Piller, L.; M. Simpson, Lara; Baraniuk, Sarah; Loghin, Catalin; Aguilar, D.; Richman, Sara; Zierold, C.; Spoon, D.; Bettencourt, J.; L. Sayre, Shelly; W. Vojvodic, Rachel; Skarlatos, S.; Gordon, D.; F. Ebert, R.; Kwak, Minjung; Moye, L.; Simari, R.

doi:10.1001/JAMA.2012.28726

Public

Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction: The TIME Randomized Trial

Shared by NobleBlocks on Dec 12, 2012 • 12:00 AM UTC

Authors:

J. Traverse

T. Henry

C. Pepine

Abstract

Context While the delivery of cell therapy following ST segment myocardial infarction (STEMI) has been evaluated in previous clinical trials, the influence of the timing of cell delivery on the effect on left ventricular (LV) function has not been analyzed in a trial that randomly designated the tim...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!